Advanced MedTech
VC Fund
Singapore, Singapore
Advanced MedTech is a VC fund in Singapore focused on Medical Device and Medical. Advanced MedTech is the largest medical device business in Southeast Asia. It is a global medical technology leader with a core focus in urology devices and services. Headquartered in Singapore, with operations in US, Germany, Spain, France, Italy, China, Malaysia and Japan, the Company serves millions of patients and physicians in 100 countriesworldwide. Advanced MedTech makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world. Advanced MedTech is a wholly-owned subsidiary of Temasek.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Advanced MedTech invests in
Stages Advanced MedTech invests in
Countries Advanced MedTech invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $10M–$11M
Investment Focus
Industry
- Medical Device 3 (60%)
- Medical 2 (40%)
- Health Care 2 (40%)
- Wearables 1 (20%)
- Biotechnology 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Series B 1 (20%)
- Series C 1 (20%)
Country
- Singapore 2 (40%)
- United States 2 (40%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abel Ang
Group CEO; Group CEO
|
Group CEO; Group CEO | Total investments: 0 | Find email | |
Gregory Miller
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Yau Chung Wong
Group CEO
|
Group CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AWAK Technologies develop wearable dialysis machines, 1kg and battery-operated, for continuous dialysis. The company was certified by SGS for ISO 13485 Quality Management System in September 2008 with the scope of designing, manufacturing and distributing medical devices.The Automated Wearable Artificial Kidney (AWAK) is based on tidalperitoneal dialysis. The technology is based on research by Profs David Lee & Martin Roberts of UCLA and VA Systems.The engineering and development of AWAK is done in Singapore with the collaboration of Temasek Polytechnic.The company has completed the R&D and is now in the clinical trial stage, targeting both FDA and CE certifications. The AWAK Regular Cartridge, is currently in pilot production stage and expected to enter clinical trial by the end of 2012. This wearable artificial kidney operates continuouslyand functions like a normal kidney. Being small , light (less than 1 kg) and battery-operated, the patients will be able to go about having daily routines, with no restriction to lifestyles such as work, travel and leisure. | $20M / Series B / Sep 13, 2023 | ||
| Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease. The company's stone repositioning solution is currently in clinical trials and its second-generation stone breaking technology is in development.Sonomotion was founded in 2014 and headquartered in South SanFrancisco, California. | $12.4M / Series C / Apr 15, 2022 | ||
| ABM Respiratory Care is a medical device startup that develops ventilation solutions for people suffering from pulmonary diseases. It launched its first televentilator, the Alpha Ventilator, designed to allow remote management and monitoring of ventilators to reduce the number of bedside visits. The company also launched the biWaze Airway ClearanceSystem, designed to provide a tailored and hygienic therapy. | $10M / Series A / Jul 14, 2020 | ||
| Advent Access is a medical technology startup in end stage renal disease management. Founded based on Stanford Biodesign principles and as a spin-off from A*STAR, Advent Access’ mission is to pioneer innovations to significantly reduce dialysis cost and restore quality of life for kidney failure patients in Asia and across the world. Advent Access’first product is the av-Guardian™ - a device that improves vascular access reliability, reduces cannulation pain and in the long run, preserves the health of an arteriovenous fistula. The av-Guardian™ forms a key component of Advent Access’ dialysis-machine agnostic platform to empower patients to perform hemodialysis independently, safely and more affordably. | $1.9M / Seed / Dec 12, 2017 | ||
| AWAK Technologies develop wearable dialysis machines, 1kg and battery-operated, for continuous dialysis. The company was certified by SGS for ISO 13485 Quality Management System in September 2008 with the scope of designing, manufacturing and distributing medical devices.The Automated Wearable Artificial Kidney (AWAK) is based on tidalperitoneal dialysis. The technology is based on research by Profs David Lee & Martin Roberts of UCLA and VA Systems.The engineering and development of AWAK is done in Singapore with the collaboration of Temasek Polytechnic.The company has completed the R&D and is now in the clinical trial stage, targeting both FDA and CE certifications. The AWAK Regular Cartridge, is currently in pilot production stage and expected to enter clinical trial by the end of 2012. This wearable artificial kidney operates continuouslyand functions like a normal kidney. Being small , light (less than 1 kg) and battery-operated, the patients will be able to go about having daily routines, with no restriction to lifestyles such as work, travel and leisure. | $11.2M / Series A / Dec 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Advanced MedTech invest in?
Advanced MedTech invests primarily in Medical Device, Medical and Health Care startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Advanced MedTech's check size?
Advanced MedTech typically joins rounds of $10M–$11M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Advanced MedTech participates in.
How do I contact Advanced MedTech?
Public channels for Advanced MedTech include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Advanced MedTech?
The team at Advanced MedTech includes Abel Ang (Group CEO; Group CEO), Gregory Miller (Chief Financial Officer) and Yau Chung Wong (Group CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
